🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

Crude Oil Moves Higher; General Motors Earnings Top Views

Published 23/04/2024, 19:31
© Reuters.  Crude Oil Moves Higher; General Motors Earnings Top Views

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on Tuesday.

The Dow traded up 0.68% to 38,499.41 while the NASDAQ rose 1.69% to 15,711.94. The S&P 500 also rose, gaining, 1.24% to 5,072.91.

Check This Out: Wall Street’s Most Accurate Analysts’ Views On 3 Energy Stocks With Over 3% Dividend Yields

Leading and Lagging Sectors

Communication services shares climbed by 2% on Tuesday.

In trading on Tuesday, materials shares fell by 0.5%.

Top Headline

General Motors Company (NYSE:GM) reported better-than-expected earnings for its fiscal first quarter.

The company posted quarterly sales growth of 7.6% year-on-year to $43.01 billion, beating the analyst consensus estimate of $41.88 billion. Adjusted EPS of $2.62 beat the consensus estimate of $2.14.

General Motors projects adjusted EPS of $9.00 – $10.00 (prior $8.50 – $9.50) versus consensus of $9.08.

Equities Trading UP

  • Hibbett, Inc. (NASDAQ:HIBB) shares shot up 19% to $86.26 after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.
  • Shares of Oportun Financial Corporation (NASDAQ:OPRT) got a boost, surging 36% to $3.0710 after the company announced preliminary first-quarter total revenue above estimates.
  • Palisade Bio, Inc. (NASDAQ:PALI) shares were also up, gaining 31% to $6.48 after the company entered into a collaboration with Strand Life Sciences.
Equities Trading DOWN

  • JetBlue Airways Corporation (NASDAQ:JBLU) shares dropped 17% to $6.24 after the company reported first-quarter financial results and issued weak FY24 revenue outlook.
  • Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO) were down 54% to $3.3950 after the company announced the FDA issued a Complete Response Letter in response to the company’s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.
  • LKQ Corporation (NASDAQ:LKQ) was down, falling 13% to $42.67 after the company reported a first-quarter earnings miss and cut its FY24 outlook.
Also Check This Out: Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying


In commodity news, oil traded up 1.8% to $83.36 while gold traded down 0.2% at $2,342.00.

Silver traded up 0.5% to $27.38 on Tuesday, while copper fell 0.9% to $4.4350.

Euro zone

European shares were higher today. The eurozone's STOXX 600 rose 1.09%, London's FTSE 100 rose 0.26% while Spain's IBEX 35 Index climbed 1.70% The German DAX gained 1.55% French CAC 40 rose 0.81% while Italy's FTSE MIB Index jumped 1.89%.

The S&P Global UK PMI composite index climbed to 54.0 in April from 52.8 in the previous month. The HCOB Eurozone composite PMI surged to 51.4 in April from 50.3 a month ago.

Asia Pacific Markets

Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 0.30%, Hong Kong's Hang Seng Index gaining 1.92%, China's Shanghai Composite falling 0.74% and India's S&P BSE Sensex gaining 0.12%.

The annual inflation rate in Hong Kong fell to 2% in March from 2.1% in the prior month. The HSBC India Composite flash PMI climbed to 62.2 in April versus a final reading of 61.8 in the earlier month. The au Jibun Bank Japan Composite PMI rose to 52.6 in April compared to a final reading of 51.7 a month ago.


  • Sales of new single-family houses jumped 8.8% month-over-month to an annualized rate of 693,000 in March, compared to a revised 5.1% decline in February.
  • The S&P Global services PMI fell to 50.9 in April, recording the weakest level in five months and missing market estimates of 52.
  • The S&P Global composite PMI fell to 50.9 in April versus 52.1 a month ago.
Now Read This: Amazon.com, United Airlines And 2 Other Stocks Insiders Are Selling

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.